Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It isn’t the biotechnology or even its efficacy.
Somehow, shrouded in secrecy and a total lack of disclosure, lies a roll-out and marketing problem. Most on this board believe Hayward is incompetent in conveying to the range of potential users of this technology, the practical applications.
I.E: good salesmen and marketers sell products and develop verticals.
Lab scientists don’t do this.
This product will not and hasn’t sold itself. The proof is in black and white, Quarter after endless Quarter.
No matter how many times I have asked about cotton, I have never received a meaningful or informative answer.
Same goes for Videojet, Techmer , Palmetto etc, etc.
I have asked for details which have been passed on to management.
Started asking about cotton 18 months ago.
Then the CC got cancelled.
Well, what happened to all the doom and gloom Cassandra’s??
Based on the replies I got from IR this week, I think Hayward cancelled the 4th quarter CC.
They are to “resume “ in February after 1st Q 2019 (fye) FS release. Hayward did not want a conference call due to the “tone “ of some investors. Dear me!!! I hope he’s not upset with our questions and queries!!
That won’t do.
I had my broker call the day they did the offering. It was not available.
That’s why I said the deal had closed a few days ago.
What looked like a public offering, never really was.
Like the baseball bet, I never accepted. Remember contract law 101: offer and acceptance
The company raised the 2.75 million on 12/26 and closed the maxim deal.
Right, and the company has no debt except bonds to insiders.
In a case like APDN, the company would scale back operations.
BK is for companies with massive debt.
That’s a $2 bet.
Houston and L.A. was 2017 I believe.
You guys got it all wrong. Note Sanjay’s “stay tuned” comment and read between the lines.
The CC has been delayed because there’s news to be released first.
Takin bets.
I’m going to be the odd man out and predict really, really good news. Hate running with the pack.
Is it old warrants about to expire??
236,600 warrants dumped today at .002.
That’s five warrants for a penny.
Here is the reply from Sanjay:
“A date for a quarterly call has yet to be set.
Stay tuned.”
Sanjay M. Hurry, Vice President
Investor Relations Counsel, Applied DNA Sciences
Haven’t heard back from Sanjay. Did you get a reply??
I have a strong feeling that merger/acquisition talks are underway.
I believe Dow Pharmaceuticals is most likely. Dow has multiple applications for this biotech and a long history of buying firms.
It would depend on who the buyout significantly benefits.
If Hayward is the mass beneficiary, it had better pass the smell test.
And it seems pretty obvious that a few shareholders have been right all along.
Basically , shareholders have financed a scientist through 20 years of research developing a product that no one seems to need.
Sent a email to Sanjay harping about everything. Asked when CC is scheduled.
I’ve said it before. I can’t ever recall in over 40 years of investing and managing client accounts, investigating thousands of companies:
A company with this number of verticals and all these license agreements going all this time without a single meaningful contract.
Himatsingka, Videojet and Colorcon are real shockers, bordering on unbutton. You’d almost think they might be ponzi setups.
After all, any rise those licenses gave the pps only led to more stock offerings.
I have to believe, since the warrants aren’t worth a penny, that the only way Hayward makes money is to issue stock.
Hayward needs to go.
It’ll take less than 3 weeks to do that. Seen this before . Deja Vu
In that case there just needs to be 2 more trading days like Friday and mission accomplished.
I went over this a year ago. And I won’t list all the verticals/licenses again.
But I started harping over a year ago. What are 60 people doing all year without a single contract. I’m calling Ripley’s. I know Hayward holds the world record.
Anyone on staff who talks about contract negotiations, imho, is full of BS.
Just take Videojet alone, 15 months later, 6 conventions and trade shows. Then.....Nothing.
Don’t even think about the Colorcon saga.
Got basically the same information from Sanjay on several occasions. He did forward my list of queries to the Board.
This shelf offering is not the problem.
Here is the problem:
ACG
Colorcon
BLC
Techmer
Videojet
Palmetto
Himatsingka
Theracan
UL
Fertilizers
Currency
Auto
Documents
Dna
All of these companies, industries and verticals lingering on and on.
Yet No contracts, No cash flow.
And yet they are waiting. Everyone is asking....waiting for what???
Mr Goodbar??
Two things:
(1) this news is not surprising or unexpected
(2) why suspend trading for this news?? It doesn’t rate as news.
25% of float swapped out in 3 hours.
Is this a Nasdaq record or what??
Don’t be surprised if the entire 18 million float swaps out today, funds and all. Year end House cleaning to boot.
Don’t be surprised if the entire 18 million float swaps out today, funds and all. Year end House cleaning to boot.
Another thing you have to ask. Why would trading suspension go for an entire day to make that announcement??
That really makes no sense at all.
True, and why would they? That many shares have now sold for 30 cents
True. And this does reset the Sabby warrants.
I have to say, I don’t understand the purpose of this.
The only thing left is the Conference Call, and frankly, Hayward is not good at this.
Do you have a link?
Per Sanjay reply, that is not true:
As stated in this morning’s preliminary press release, the 10-K will be issued the week of December 17 and a conference call to be held the week after.
I’ll relay your comments to management. The status updates you requested may be addressed on the conference call.
With regard to the recent convertible note offering the phrase “will be secured by substantially all assets of the Company” is customary legal language to denote that, upon default, assets valued at $2.25M (the amount raised under the offering) would revert to the Note holders and nothing more beyond that amount. It does not imply that all of the company’s assets will revert to the Note holders in lieu of their $2.25M investment. As such, there is no basis for ‘diminished investor faith in the prospect of ‘going concern’”, as you put it.
Terms of the offering are found here: https://www.sec.gov/Archives/edgar/data/744452/000114420418047690/tv502211_8k.htm
Trading halt still in effect. Pending news.
The last time I held shares in a company that halted trading an entire day was a merger.
USHG merged with a high tech plasma laser company. About 15 years ago.
When was the last time they shut down trading for an entire day for a news announcement??
I can’t find where they ever have.
Well, you’ll either be in Palm Beach or Bird Haven indigent retirement home.
There are only 2 things posted on Maxim:
Applied DNA Sciences trading halted, news pending
Read more at:
https://thefly.com/landingPageNews.php?id=2839979
That shelf offering is almost a year old so it in no way is material:
“The securities described above are being offered under the Company’s shelf registration statement on Form S-3 (No. 333-218158), previously filed with and declared effective by the U.S. Securities and Exchange Commission (SEC). “
The shelf offering is old news.
The code is T1. Halted pending material news.
This is not a volume or price related halt. So T1 means “material news”.
Shark, any take on halt due to “pending news”??
Reverse merger?